FDA panel overwhelmingly votes against experimental ALS treatment pushed by patients - CBS News
cbsnews.comSubmitted by cbsnews1121 in business
Federal health advisors voted 17-1 against an experimental treatment for Lou Gehrig's disease dubbed NurOwn, although the FDA is not bound by the vote.